Venetoclax
Showing 351 - 375 of 485
MDS (MDS) Trial in Worldwide (Azacitidine, Venetoclax)
Active, not recruiting
- Myelodysplastic Syndromes (MDS)
- Azacitidine
- Venetoclax
-
Tucson, Arizona
- +36 more
Aug 1, 2022
Relapsed or Refractory Chronic Lymphocytic Leukemia
Recruiting
- Chronic Lymphocytic Leukemia
- +2 more
- Venetoclax
-
Cona, Ferrara, Italy
- +26 more
Jan 3, 2022
Acute Myeloid Leukemia Trial in Worldwide (Magrolimab, Venetoclax, Azacitidine)
Active, not recruiting
- Acute Myeloid Leukemia
- Magrolimab
- +6 more
-
Duarte, California
- +25 more
Feb 4, 2022
Hematologic Malignancy, Stem Cell Transplant Complications Trial in Hangzhou (Azacitidine in Combination With Venetoclax)
Recruiting
- Hematologic Malignancy
- Stem Cell Transplant Complications
- Azacitidine in Combination With Venetoclax
-
Hangzhou, Zhejiang, ChinaThe first Affiliated Hospital of Zhejiang University
Mar 24, 2021
Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Venetoclax, Obinutuzumab)
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- Venetoclax
- Obinutuzumab
-
La Jolla, California
- +41 more
Aug 10, 2022
Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast
Terminated
- Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast Cancer
- Venetoclax
- Fulvestrant
-
Phoenix, Arizona
- +39 more
Jun 21, 2022
Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston
Active, not recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +8 more
- DS-1594b
- +14 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2022
Non-Hodgkin Lymphoma (NHL), Multiple Myeloma (MM), Chronic Lymphocytic Leukemia (CLL) Trial in Japan (azacitadine, venetoclax,
Completed
- Non-Hodgkin Lymphoma (NHL)
- +4 more
- azacitadine
- +2 more
-
Nagoya shi, Aichi, Japan
- +13 more
Jul 29, 2021
Leukemia, Myeloid, Acute, De Novo, Age More 60yr Trial in Spain (Azacitidine, Venetoclax, Quizartinib)
Recruiting
- Leukemia, Myeloid, Acute
- +2 more
- Azacitidine
- +3 more
-
Alcalá De Henares, Spain
- +14 more
May 17, 2021
Lymphoma, Mantle-Cell, Recurrent Lymphoma, Mantle-Cell Trial in United States (ABT-199 and Ibrutinib Combination)
Completed
- Lymphoma, Mantle-Cell
- Recurrent Lymphoma, Mantle-Cell
- ABT-199 and Ibrutinib Combination
-
Duarte, California
- +3 more
May 22, 2022
Hematopoietic Cell Transplantation Recipient, Recurrent DLBCL, Recurrent Grade 1 Follicular Lymphoma Trial in Columbus
Active, not recruiting
- Hematopoietic Cell Transplantation Recipient
- +11 more
- Carmustine
- +5 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 29, 2021
Previously Untreated Acute Myeloid Leukemia Trial in United States (biological, other, drug)
Recruiting
- Previously Untreated Acute Myeloid Leukemia
- Samalizumab (BAML-16-001-S1)
- +32 more
-
Phoenix, Arizona
- +18 more
Oct 17, 2022
Hypomethylating Agents and Venetoclax in Newly Diagnosed Acute
Recruiting
- Acute Myeloid Leukemia, Adult
- +2 more
- Venetoclax
-
Trieste, ItalySC Ematologia Ospedale Maggiore
Sep 14, 2020
Acute Myeloid Leukemia Trial in Worldwide (Magrolimab, Venetoclax, Azacitidine)
Recruiting
- Acute Myeloid Leukemia
- Magrolimab
- +3 more
-
Little Rock, Arkansas
- +82 more
Jan 17, 2023
Acute Myeloid Leukemia Trial in United States (CPX-351, Venetoclax, Midostaurin)
Active, not recruiting
- Acute Myeloid Leukemia
- CPX-351
- +3 more
-
Duarte, California
- +9 more
Jan 3, 2023
Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Obinutuzumab, Venetoclax, Fludarabine)
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- Obinutuzumab
- +5 more
-
Aurora, Colorado
- +55 more
Jan 30, 2023
Lymphoma, B-Cell Trial in Vancouver, Toronto, Montreal (Venetoclax, RiTUXimab Injection, Rituximab SC)
Recruiting
- Lymphoma, B-Cell
- Venetoclax
- +5 more
-
Vancouver, British Columbia, Canada
- +2 more
Jan 24, 2022
AL Amyloidosis Trial in Boston (Venetoclax, Dexamethasone)
Terminated
- AL Amyloidosis
- Venetoclax
- Dexamethasone
-
Boston, MassachusettsTufts Medical Center
Aug 19, 2020
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Pirtobrutinib, Venetoclax, Rituximab)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Pirtobrutinib
- +2 more
-
Phoenix, Arizona
- +116 more
Jun 27, 2022
Recurrent Acute Myeloid Leukemia Trial in Duarte (Bosutinib Monohydrate, Decitabine, Enasidenib Mesylate)
Withdrawn
- Recurrent Acute Myeloid Leukemia
- Bosutinib Monohydrate
- +6 more
-
Duarte, CaliforniaCity of Hope Meidcal Center
Jun 7, 2022